The functional variants that causes reduced function of OATP1B1 and identified as increasing the risk of statin myopathy (rs414056 and rs4363657 and variants in linkage disequilibrium with them) are the most strongly associated with higher levels of hexadecanedioate. Here, SLCO1B1 is linked to myopathy.